www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

Bangkok, February 4, 2013 ? The SEC together with the Interior Ministry, National Science and Technology Development Agency (NSTDA), the Stock Exchange of Thailand (SET), the Federation of Thai

capital) to meet and develop networks through a variety of activities, such as focus groups, seminars, training, websites or social networking, etc. This is to make another step forward, after the SEC?s

Ref. AU 009/2017 - Translation - 15 May 2017 To: Director and the President The Stock Exchange of Thailand Management Discussion and Analysis for the three-month period ended 31 March 2017 After You

Ref. AU 011/2017 - Translation - 11 August 2017 To: Director and the President The Stock Exchange of Thailand Management Discussion and Analysis for the six-month period ended 30 June 2017 After You

: Management Discussion and Analysis for the year ended 31 December 2017 To : The President The Stock Exchange of Thailand Summary of the Company’s Financial Position and Operating Result for the year ended 31

: Management explanation and analysis for the 2nd Quarter ended 30 June 2018 Attention : The President of, The Stock Exchange of Thailand ZIGA Innovation Public Company Limited (“ the Company”) would like to

14 November 2019 Subject: Management Discussion and Analysis for the 9-Month Period Ended September 30, 2019 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public

securities, as well as the suitability for investment and the relevant risk exposure. The effectiveness of the Registration Statement neither represents that the Securities and Exchange Commission, the Capital

Definition of “Executives” under Chapter 3/1 of the Securities and Exchange Act B.E. 2535 (1992) as Amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008)